Date of last update: April 4, 2012
Canada is a participant to Mutual Recognition Agreements (MRAs), covering drug/medicinal products Good Manufacturing Practices (GMP) Compliance Programmes, with the Parties listed below:
The equivalency of the GMP Compliance Programmes is determined according to a three (3) phase confidence building process:
The results of the evaluation are based on objective assessment criteria and documented evidence and are used to determine equivalency. The evaluation results remain valid as long as the agreement between the two parties is in effect and where no significant changes to the GMP Compliance Programmes have been introduced.